Y K Hamied

Title: Y K Hamied: Innovator in Pharmaceutical Compositions

Introduction

Y K Hamied is a prominent inventor based in Mumbai, India. He is known for his significant contributions to the field of pharmaceuticals, particularly in the formulation of innovative drug delivery systems. His work has had a substantial impact on the way certain medications are administered, enhancing their effectiveness and bioavailability.

Latest Patents

Y K Hamied holds a patent for a unique pharmaceutical composition that involves water-insoluble pharmaceutically active substances, such as cyclosporin. This invention formulates these substances for administration in the form of an oil-in-water microemulsion. In this formulation, the active substance is fully dissolved in dispersed oil particles, which are derived from C.sub.8 to C.sub.20 fatty acid vegetable oil glycerides. The microemulsion is stabilized with lecithin and another surfactant, while the hydrophilic phase comprises propylene glycol. This innovative approach allows for the creation of soft gelatine capsules or oral administration fluids, significantly improving the delivery of these medications.

Career Highlights

Y K Hamied is associated with Byron Fine Chemicals Inc., where he continues to develop and refine pharmaceutical formulations. His expertise in the field has led to advancements that benefit both healthcare providers and patients alike. His dedication to innovation in pharmaceuticals is evident through his patent and ongoing research efforts.

Collaborations

Y K Hamied has worked alongside notable colleagues, including Geena Malhotra and V G Nayak. These collaborations have fostered an environment of creativity and innovation, contributing to the development of effective pharmaceutical solutions.

Conclusion

Y K Hamied's contributions to pharmaceutical compositions exemplify the importance of innovation in medicine. His work not only enhances drug delivery systems but also improves patient outcomes. His dedication to research and development continues to inspire advancements in the pharmaceutical industry.